Rhythm Pharmaceuticals
RYTM
RYTM
55 hedge funds and large institutions have $485M invested in Rhythm Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 19 increasing their positions, 16 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
55
Holders Change
-11
Holders Change %
-16.67%
% of All Funds
1.26%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.07%
New
6
Increased
19
Reduced
16
Closed
17
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$6.76M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$2.37M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$1.99M |
| 4 |
Russell Investments Group
London,
United Kingdom
|
+$1.34M |
| 5 |
JPMorgan Chase & Co
New York
|
+$786K |
Top Sellers
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
-$4.21M |
| 2 |
PA
Perceptive Advisors
New York
|
-$3.04M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$2.94M |
| 4 |
Franklin Resources
San Mateo,
California
|
-$2.77M |
| 5 |
LCM
Laurion Capital Management
New York
|
-$1.61M |
